Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2 ...

For patients with opioid use disorder (OUD) and alcohol use disorder (AUD), prescriptions of glucose-dependent insulinotropic ...

News and talk of GLP-1 drugs are everywhere these days—from their smash success in treating Type 2 diabetes and obesity to ...

A new study by researchers at Brigham and Women's Hospital in collaboration with researchers at Harvard T.H. Chan School of ...

Taking a GLP-1 receptor agonist was associated with a lower risk for cirrhosis and related complications in patients with ...

The demand for bariatric operations dropped sharply last year as use of anti-obesity drugs such as Wegovy surged, study finds ...

Reviewed by Dietitian Emily Lachtrupp, M.S., RD Ever since berberine made headlines last year for being touted as “nature’s ...

A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing ...

The health secretary said the injections are not 'cosmetic' treatments and should only be used by obese people who have ...

Centene's Medicaid revenue fell slightly in the third quarter as costs outpaced the payment increases states implemented.

In a world increasingly focused on health and wellness, finding effective solutions for weight management can be challenging.

Multiple sessions and virtual care companies touted the potential of glucagon-like peptide-1 agonist drugs to help patients ...